Phenylketonuria : a study showed study improvements in cognitive function, anxiety, and depression ratings associated with resumption of dietary control of phenylketonuria Consult the pubmed abstract To read more about “Phenylketonuria” Orphanet J Rare Dis . 2021 Jan 18;16(1):35. (Source: OrhpaNews 10 May 2021) Related news Appropriate consent and health rights of children: Understanding the ethics of genomic newborn screening A new article has been published in the European Journal of Human Gene... Understanding the role of patient organisations in promoting and developing newborn screening A new article has been published in Rare Disease and Orphan Drugs Jour... The WHO/World Health Assembly adopts resolution concerning maternal, newborn and child mortality The WHO/World Health Assembly adopts resolution A77/A/CONF./5 “A... Dominican Republic moves to implement neonatal screening Please see this link: https://dominicantoday.com/dr/health/2024/04/09/... Methods for estimating rare disease prevalence A new article has been published in Rare Disease and Orphan Drugs Jour... New European Commission fact sheet on rare diseases The European Commission has published a new fact sheet titled “EU Ac...